Class I - Dangerous
Marketed Without an Approved NDA/ANDA: The product is an unapproved new drug.
Marketed Without an Approved NDA/ANDA: The product is an unapproved new drug.
Marketed Without an Approved NDA/ANDA: The product is an unapproved new drug.
Marketed Without an Approved NDA/ANDA: The product is an unapproved new drug.